TP53 and head and neck squamous cell carcinoma: At the molecular level, HNSCC is marked by frequent mutations in tumor suppressor genes such as tumor protein p53 (TP53), cyclin-dependent kinase inhibitor 2A, and neurogenic locus notch homolog protein 1, as well as amplifications in oncogenes including cyclin D1 and epidermal growth factor receptor [18,19].